PREVISEA Trademark

Trademark Overview


On Friday, March 11, 2022, a trademark application was filed for PREVISEA with the United States Patent and Trademark Office. The USPTO has given the PREVISEA trademark a serial number of 97307047. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, June 13, 2025. This trademark is owned by Entac Medical, Inc.. The PREVISEA trademark is filed in the Medical Instrument Products category with the following description:

Medical devices for use in diagnosing postoperative diseases and disorders associated with a patient's digestive system; medical devices for use in treating or diagnosing postoperative diseases and disorders associated with a patient's digestive system with integrated recorded operating system software, sold as a unit; medical hearing instruments and parts of such devices
previsea

General Information


Serial Number97307047
Word MarkPREVISEA
Filing DateFriday, March 11, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, June 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements


Goods and ServicesMedical devices for use in diagnosing postoperative diseases and disorders associated with a patient's digestive system; medical devices for use in treating or diagnosing postoperative diseases and disorders associated with a patient's digestive system with integrated recorded operating system software, sold as a unit; medical hearing instruments and parts of such devices

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, March 13, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEntac Medical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMemphis, TN 38117

Party NameEntac Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMemphis, TN 38117

Trademark Events


Event DateEvent Description
Friday, December 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 15, 2022NEW APPLICATION ENTERED
Wednesday, March 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 19, 2022ASSIGNED TO EXAMINER
Friday, December 23, 2022NON-FINAL ACTION WRITTEN
Friday, December 23, 2022NON-FINAL ACTION E-MAILED
Monday, March 13, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, March 13, 2023EXAMINERS AMENDMENT E-MAILED
Monday, March 13, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 13, 2023EXAMINER'S AMENDMENT ENTERED
Monday, March 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 12, 2023SOU EXTENSION 1 FILED
Tuesday, December 12, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 12, 2023SOU EXTENSION 1 GRANTED
Thursday, December 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2024SOU EXTENSION 2 GRANTED
Wednesday, June 12, 2024SOU EXTENSION 2 FILED
Friday, June 13, 2025SOU EXTENSION 4 FILED
Friday, June 13, 2025SOU TEAS EXTENSION RECEIVED
Friday, June 13, 2025SOU EXTENSION 4 GRANTED
Friday, June 13, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 11, 2024SOU EXTENSION 3 FILED
Monday, December 23, 2024SOU EXTENSION 3 GRANTED
Wednesday, December 11, 2024SOU TEAS EXTENSION RECEIVED